Literature DB >> 30332659

Clinical and electrographic characteristics of seizures in LGI1-antibody encephalitis.

Li-Hao Li1, Cong-Cong Ma1, Hai-Feng Zhang1, Ya-Jun Lian2.   

Abstract

PURPOSE: The purpose of this study was to analyze the clinical and electrographic characteristics of seizures in LGI1-antibody encephalitis.
METHODS: The methods utilized in this study were prospective analysis of the clinical manifestations, types of seizures, electroencephalogram (EEG), adjuvant examination, treatment and prognosis of 19 cases of LGI1-antibody encephalitis diagnosed from January 2017 to February 2018 in First Affiliated Hospital of Zhengzhou University, and reviewed related literatures.
RESULTS: The 15/19 (79%) patients were male, and the average onset age was 58 years (23-82). The following cases were observed: 17 (89%) with epilepsy seizures, 14 (73%) with mental disorders, and 13 (68%) with cognitive impairment. Types of epilepsy were including focal aware seizures, focal-impaired awareness seizures, focal to bilateral tonic-clonic seizures, and status epilepticus. The motor events were most commonly clonus or automatisms, and the sensory events were frequently body shuddering. The 13 patients had faciobrachial dystonic seizures (FBDS); the median frequency was 48 per day (range 5-180). In some video-EEGs, multifocal ictal epileptiform discharges from frontal, temporal, and apical regions, and interictal slow wave activity were observed in patients. Normal EEG appeared in all patients during FBDS. Five patients had hyponatremia, and brain magnetic resonance imaging (MRI) results of 5 cases were abnormal. All patients were treated with antiepileptic drugs and immunotherapy, and their clinical symptoms were improved. During the follow-up period, 13 patients recovered basically, and 6 patients relapsed. One patient died of status epilepticus after relapse.
CONCLUSIONS: Faciobrachial dystonic seizure and various types of epileptic seizures are characteristic manifestations of LGI1-antibody encephalitis, which can assist in early diagnosis. Once this has been diagnosed, antiepileptic drugs and immunotherapy should be given as soon as possible to the patient.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autoimmune encephalitis; Epilepsy; FBDS; LGI1; Neuroimmunology

Mesh:

Substances:

Year:  2018        PMID: 30332659     DOI: 10.1016/j.yebeh.2018.08.019

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  9 in total

1.  Clinical Features and Long-Term Outcomes of Anti-Leucine-Rich Glioma-Inactivated 1 Encephalitis: A Multi-Center Study.

Authors:  Shan Qiao; Huai-Kuan Wu; Ling-Ling Liu; Mei-Ling Wang; Ran-Ran Zhang; Tao Han; Xue-Wu Liu
Journal:  Neuropsychiatr Dis Treat       Date:  2021-01-25       Impact factor: 2.570

2.  Neuropsychological Performance in Autoimmune Limbic Encephalitis: Evidence from an Immunotherapy-Naïve Cohort.

Authors:  Christoph Mueller; Lisa Langenbruch; Johanna M H Rau; Tobias Brix; Christine Strippel; Andre Dik; Kristin S Golombeck; Constanze Mönig; Andreas Johnen; Saskia Räuber; Heinz Wiendl; Sven G Meuth; Jens Bölte; Stjepana Kovac; Nico Melzer
Journal:  Arch Clin Neuropsychol       Date:  2022-05-16       Impact factor: 3.448

3.  Clinical and Electroencephalographic Features of the Seizures in Neuronal Surface Antibody-Associated Autoimmune Encephalitis.

Authors:  Yan Wang; Yi Yu; Yaping Hu; Ying Li; Fan Song; Ying Wang
Journal:  Front Neurol       Date:  2020-05-05       Impact factor: 4.003

4.  Clinical Features and Therapeutic Effects of Anti-leucine-rich Glioma Inactivated 1 Encephalitis: A Systematic Review.

Authors:  Yuou Teng; Ting Li; Zhizhong Yang; Mingwan Su; Jingnian Ni; Mingqing Wei; Jing Shi; Jinzhou Tian
Journal:  Front Neurol       Date:  2022-01-12       Impact factor: 4.003

5.  Case Report: Paroxysmal hyperhidrosis as an initial symptom in a patient with anti-LGI1 encephalitis.

Authors:  Tingting Qiao; Lanlan Chen; Li Jiang; Hua Wei; Xin Chen; Xiaobo Li; Yingzhu Chen; Yao Xu
Journal:  Front Immunol       Date:  2022-09-23       Impact factor: 8.786

6.  Characteristics and outcome-related factors of seizure at the first onset of autoimmune encephalitis: A retrospective study.

Authors:  Yilin Wang; Xin Li; Pingping He; Jiangning Yin; Ruofei Dong; Yu Fu; Hong Zhang
Journal:  CNS Neurosci Ther       Date:  2021-03-08       Impact factor: 5.243

7.  Clinical Features and Gut Microbial Alterations in Anti-leucine-rich Glioma-Inactivated 1 Encephalitis-A Pilot Study.

Authors:  Xueying Ma; Lili Ma; Zhanhang Wang; Yingying Liu; Ling Long; Xiaomeng Ma; Hao Chen; Zhaoyu Chen; Xiuli Lin; Lei Si; Xiaohong Chen
Journal:  Front Neurol       Date:  2020-10-27       Impact factor: 4.003

Review 8.  Anti-LGI1, anti-GABABR, and Anti-CASPR2 encephalitides in Asia: A systematic review.

Authors:  Prinska Ghimire; Ujjwal Prakash Khanal; Bikram Prasad Gajurel; Ragesh Karn; Reema Rajbhandari; Sunanda Paudel; Niraj Gautam; Rajeev Ojha
Journal:  Brain Behav       Date:  2020-08-12       Impact factor: 2.708

9.  Recognition of seizure semiology and semiquantitative FDG-PET analysis of anti-LGI1 encephalitis.

Authors:  Tao-Ran Li; Yu-Di Zhang; Qun Wang; Xiao-Qiu Shao; Rui-Juan Lv
Journal:  CNS Neurosci Ther       Date:  2021-07-22       Impact factor: 5.243

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.